CMS opens door for PET coverage for oncologic uses

03/9/2013 | HealthImaging.com · MedPage Today (free registration)

CMS has lifted the non-coverage decision for PET imaging for oncologic procedures, allowing local Medicare administrators to make decisions about coverage. The ruling, however, does not apply to cardiac and neurologic uses. SNMMI and other groups had lobbied for a broader decision. The decision applies to use of C-11 choline and other PET imaging agents for oncologic applications. The ruling does not address PET agents FDG, NaF-18, ammonia N-13 and rubidium-82, which already have been addressed with coverage determinations.

View Full Article in:

HealthImaging.com · MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel, Regulatory
Cardinal Health
Waukegan, IL
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Sr Manager, Business Conduct
Gilead Sciences
Foster City, CA
Chief Executive Officer
UCare Minnesota
Minneapolis, MN